The burden of cardiovascular disease (CVD) has increasingly shifted toward low- and middle-income countries.1 As the prevalence of noncommunicable diseases rapidly increases in these settings, their health systems are grappling with how to provide high-quality care with limited resources. A key target of the United Nations Sustainable Development Goals adopted by world leaders in 2015 is to reduce premature mortality from noncommunicable diseases by one-third by 2030.2 Meeting this goal will require accelerating implementation of effective, equitable, and resilient CVD prevention interventions for populations in low- and middle-income countries.